A Pregnant Patient with Poly-Substance Use Disorder - June 16, 2021
Claiming Credit
Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.
Target Audience
Primary Care Physicians, Internists, Family Practice Physicians, Nurse Practitioners, Nurses, and Physician Assistants
Learning Objectives
Upon completion of this activity, participants will be able to
- Understand how pregnancy shapes perceptions, impacts clinical assessment, and changes diagnostic and therapeutic clinical decision making
- Describe optimal approaches to working with and supporting patients who pregnant and struggling with SUD a/o Serious Mental Illness
- Describe the goals of care when using opioid agonist medications for OUD in patient who are pregnant
- Describe the difference between Chapters 35 and 12 in terms of use for patients in high-risk clinical situations that place them or others at risk for “Serious Harm”
- Understand how MCSTAP can help by supporting clinicians at the Point of Care
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of opioid education.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 MA Opioid Education Statement
- 1.00 Participation